Search

everythinglearnresearchcommunity

for

Search:↓

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Lasers can trigger skin reactions, especially in darker skin, and more research is needed to improve treatments.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

Many substances, including chemicals and metals, can cause skin reactions; careful handling and identification of allergens are crucial to prevent dermatitis.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Some vaccines might rarely cause hair loss, more research is needed.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The document concludes that more research is needed to confirm if COVID-19 vaccines cause a type of hair loss called alopecia areata.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

Syphilis is becoming more common and remains a major health problem due to challenges in prevention and treatment.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

People in high-income countries are more likely to accept COVID-19 booster doses than those in middle or low-income countries.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

All HPV vaccine studies should be registered and published to reduce reporting bias.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

A woman's complete hair loss condition improved after recovering from COVID-19.

Understanding cultural practices and skin reactions is crucial for diagnosing and treating skin conditions in children with dark skin.

Recurrent furunculosis can be managed with antibiotics, decolonization, and decontamination, with potential future use of vaccines and bacteriophage therapy.

Swellable microneedles could improve drug delivery and diagnostics but need more research on materials and technology integration.

Beta-HPV and MCPyV are linked to certain skin cancers, with ongoing research and vaccine development.

COVID-19 vaccines do not increase the risk of alopecia areata.